Eflornithine hydrochloride bulk supplier for pharma manufacturers

Eflornithine Hydrochloride 13.9% Suppliers & Bulk Manufacturers

Available Forms: Creams

Available Strengths: 13.9%

Reference Brands: Vaniqa (USA/EU)

Eflornithine cream is used to reduce unwanted facial hair growth in women by inhibiting an enzyme involved in hair follicle function. The injectable form is used for the treatment of sleeping sickness caused by Trypanosoma brucei gambiense.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Eflornithine Hydrochloride — third party manufacturing & bulk supply

Eflornithine Hydrochloride 13.9% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Eflornithine Hydrochloride is supplied as Creams — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Eflornithine Hydrochloride listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Eflornithine Hydrochloride →

Back to Listing

Frequently Asked Questions

Eflornithine hydrochloride is listed as Creams in 13.9%. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Eflornithine hydrochloride is referenced against Vaniqa (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.